News
SCNI
1.550
-16.67%
-0.310
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 3d ago
Scinai Files Prospectus For Resale Of Up To 2,706,450 ADS By YA II PN
Benzinga · 3d ago
Scinai registers to sell 2.71M ADSs for holders
TipRanks · 3d ago
Scinai regains Nasdaq minimum bid price compliance; shares up
Seeking Alpha · 09/21 13:03
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 09/21 12:06
Scinai Immunotherapeutics Restores Nasdaq Minimum Bid Price Compliance
TipRanks · 09/21 11:27
Scinai Immunotherapeutics Regains Nasdaq Compliance
Benzinga · 09/21 11:11
Weekly Report: what happened at SCNI last week (0914-0918)?
Weekly Report · 09/21 09:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 09/15 21:06
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 09/15 17:06
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 09/15 12:05
Why Veea Shares Are Trading Higher By 58%; Here Are 20 Stocks Moving Premarket
Benzinga · 09/15 09:18
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 09/14 17:06
Nasdaq Down Over 200 Points; Cellectis Shares Plunge
Benzinga · 09/14 14:07
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 09/14 12:06
Why Scholar Rock Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Benzinga · 09/14 09:50
Weekly Report: what happened at SCNI last week (0907-0911)?
Weekly Report · 09/14 09:06
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 09/11 21:06
Scinai Shifts Capital to NanoAb Platform and CDMO Growth After Ending PC111 Deal
TipRanks · 09/08 14:30
Scinai Immunotherapeutics refocuses capital on NanoAb platform and CDMO business
TipRanks · 09/08 13:25
More
Webull provides a variety of real-time SCNI stock news. You can receive the latest news about Scinai Immunotherapeutics Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About SCNI
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.